Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
The New Zealand Medical Journal
|
April 25, 1984
Management of hypercholesterolaemia and cholestyramine
E R Nye, P J Scott, E D Janus
Clinical Endocrinology
|
October 1, 1995
Elevated serum lipoprotein(a) in subclinical hypothyroidism
A W Kung, R W Pang, E D Janus
Journal of Lipid Research
|
November 1, 1982
Genetic variation in human apolipoprotein E
M R Wardell, P A Suckling, E D Janus
The New Zealand Medical Journal
|
March 12, 1986
Familial type V hyperlipoproteinaemia in identical twins homozygous for apoliprotein variant E2: report
E R Nye, W H Sutherland, E D Janus
Proceedings of the Royal Society of Medicine
|
January 1, 1976
The evaluation of lipoprotein changes during gemfibrozil treatment
E D Janus, D Costa, I C Ononogbu, et al.
Circulation
|
December 1, 1996
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology
E D Janus, A Postiglione, R B Singh, et al.
Australian and New Zealand Journal of Medicine
|
June 1, 1994
Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema
L Cook, E D Janus, S Brenton, et al.
Chinese Medical Journal
|
June 1, 1997
Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populations
R W Pang, B Chen, E D Janus, et al.
Journal of Epidemiology and Community Health
|
September 1, 1986
Trends in blood lead levels in Christchurch (NZ) and environs 1978-85
D Hinton, P A Coope, W A Malpress, et al.
Atherosclerosis
|
November 1, 1985
Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment
E D Janus, S Grant, C J Lintott, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
The New Zealand Medical Journal
|
April 25, 1984
Management of hypercholesterolaemia and cholestyramine
E R Nye, P J Scott, E D Janus
Clinical Endocrinology
|
October 1, 1995
Elevated serum lipoprotein(a) in subclinical hypothyroidism
A W Kung, R W Pang, E D Janus
Journal of Lipid Research
|
November 1, 1982
Genetic variation in human apolipoprotein E
M R Wardell, P A Suckling, E D Janus
The New Zealand Medical Journal
|
March 12, 1986
Familial type V hyperlipoproteinaemia in identical twins homozygous for apoliprotein variant E2: report
E R Nye, W H Sutherland, E D Janus
Proceedings of the Royal Society of Medicine
|
January 1, 1976
The evaluation of lipoprotein changes during gemfibrozil treatment
E D Janus, D Costa, I C Ononogbu, et al.
Circulation
|
December 1, 1996
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology
E D Janus, A Postiglione, R B Singh, et al.
Australian and New Zealand Journal of Medicine
|
June 1, 1994
Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema
L Cook, E D Janus, S Brenton, et al.
Chinese Medical Journal
|
June 1, 1997
Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populations
R W Pang, B Chen, E D Janus, et al.
Journal of Epidemiology and Community Health
|
September 1, 1986
Trends in blood lead levels in Christchurch (NZ) and environs 1978-85
D Hinton, P A Coope, W A Malpress, et al.
Atherosclerosis
|
November 1, 1985
Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment
E D Janus, S Grant, C J Lintott, et al.
Page
of 10